PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-CancerWei Huang, Junli Ding, Yuxin Shi et al.|Pharmacogenomics and Personalized Medicine|2023Cited by 6